Dr. Swapnil Parchand

Consultant, Retina and Uvea Services, MGM Eye Institute, Raipur

1 article

Dr Swapnil Madhukar Parchand completed his MS (Ophthalmology) from prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh in 2010. He was also awarded DNB Degree in Ophthalmology. He was awarded FAICO Fellowship degree in Retina and Vitreous by AIOS in 2019. He was Senior Resident in Retina and Uveitis Services at PGIMER, Chandigarh from 2010 to 2013. After completing his Senior Residency, he worked as Assistant Professor in Department of Ophthalmology at Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry from 2014 to 2017. He was incharge of Retina, Uveitis and Retinopathy of Prematurity (ROP) Services at JIPMER. He joined MGM Eye Institute in 2017 as Consultant in Vitreo-retina and Uveitis Services. His areas of interest are Retinal diseases, uveitis, ROP and ocular trauma. Dr Swapnil M Parchand has presented many research papers in various National and International conferences. He is reviewer of International Journals like Ocular Immunology and Inflammation, International Ophthalmology, Indian Journal of Ophthalmology and BMJ Case Reports. To his credit he has more than 25 publications in reputed national and international journals highlighting his work in Retina and Uveitis.

  1. Articles 1 Apr 2021 19 min read

    Cytomegalovirus Retinitis Simplified

    Introduction: Cytomegalovirus (CMV) retinitis is an opportunistic viral posterior uveitis that occurs mostly in severely immunocompromised Acquired Immunodeficiency Syndrome (AIDS) patients or, rarely, in those on immunosuppressive therapy after organ transplantation, or who are on systemic corticosteroids.1 More than 75% of AIDS patients with CD4+ counts less than 50 cells/?L have CMV retinitis. It is the most common ocular opportunistic infection in AIDS patients and accounts for 75-85% of all CMV end-organ disease.2 Before the introduction of Highly Active Antiretroviral Treatment (HAART), 30% of patients with Human Immunodeficiency Virus (HIV) developed CMV retinitis during their lifetime, but with the advent of HAART, there is a 75% reduction in the number of new cases of CMV retinitis.3 Rarely, CMV retinitis may occur in non-HIV patients having some degree of immune dysfunction, such as advanced age, diabetes mellitus, corticosteroid, and non-cytotoxic immunosuppressive drug usag

    Dr. Swapnil Parchand · Dr. Anil Gangwe